Jiankang (Jack) Zhang

 CEO

        As a seasoned professional executive, Mr. Zhang has been working in biomedical companies and global public health institution for more than three decades. His career has covered across from state-owned enterprise, foreign enterprise, international health institution and private company. His previous positions included the Deputy Managing Director of Shanghai Institute of Biological Products, a subsidiary of China National Biotech Group, General Manager of Haemonetics China Subsidiary, Chief Representative of PATH China office, and Chief Operation Officer of Ustar (Hangzhou) Biotechnology Co., Ltd.

        Mr. Zhang owned an MBA from China Europe International Business School (CEIBS) in Shanghai, China, a master of Medical Library and Information Sciences (MLIS) from Dominican University, Illinois, USA, a Bachelor of Arts from Fudan University, Shanghai China, and a diploma in public health issued by Shanghai Municipal Health Bureau.

Chenliang Zhou  Ph.D

Executive Vice President

        Dr. Zhou has been promoted as Executive Vice President since May 2022. He is fully accountable for the company's Basic Research Department, Technology Development Department, and R&D project management. In addition, he assists the CEO with overall operations of the company.

       Joined Shanghai Zerun in 2015，Dr. Zhou has consecutively served as R&D engineer, supervisor and manager of Basic Research Department, director of upstream R&D department, and executive vice president. He has rich experience in new vaccine R&D development and project management as well as strong team management capabilities.    

      Dr. Zhou holds a bachelor's degree in animal science from Jilin University and a doctorate in pathogen biology from Shanghai Medical College, Fudan University, and has a title of senior engineer. So far, he has published 10 academic papers, obtained 5 ized invention patents, and 14 pending patents. In 2019, he was awarded the title of Shanghai Youth Science and Technology Rising Star.

Zhiying Cui

 Vice President

        Zhiying Cui has served as Vice President since April 1, 2021, and is accountable for quality management and operational assurance of the company.

        She joined Zerun in 2006, and her role has ranged from Production QC and QA engineer, QA manager, director of Quality Management and Regulatory Affairs, and to vice president. Ms. Zhiying Cui has over 20 years of experience in vaccine R&D and production quality management in the biopharmaceutical industry. She is familiar with laws and regulations concerning the new version of GMP, ICH and WHO vaccine Pre-qualification. She has accumulated extensive experience in vaccine quality management and regulatory compliance. Prior to joining Zerun, Ms. Cui worked at Beijing Institute of Biological Products Co., Ltd, and Shanghai Huatai Biotechnology Co., Ltd., Fosun Pharma.

        Ms. Cui holds a master degree in International Pharmaceutical Engineering Management（IPEM）from Peking University and senior professional title.

Jiao An, Ph. D, 

Vice President 

        Dr. An has been promoted to the Vice President since May 2022, and is fully accountable for the development, optimization and characterization of upstream, downstream and formulation processes, and also the establishment of pilot process and pilot production.

        Dr. An has rich experience in novel vaccine design and process development, and good team management skills. She joined Shanghai Zerun in 2018, and has served as senior researcher, and manager of the Technology Development Department, director of the Process R&D Departments, and vice president. Prior to joining Zerun, she served in WuXi AppTec (Shanghai) Co., Ltd., working on protein crystallization, structure determination and functional analysis. 

        Dr. An holds a bachelor's degree and a doctorate in biology from Jilin University. She has published seven papers, obtained two ized invention patent and two pending patents.

Lingyun Zhou, Ph. D, 

Vice President 

        Dr. Zhou Lingyun has served as the vice president since November 2022, and is fully accountable for quality research and control, analytical method development, optimization and validation of all the products under development.

        Since joining Shanghai Zerun in 2011, Dr. Zhou Lingyun has successively served as the engineer, deputy manager, manager, director of the Quality Research Department and vice president. She is experienced in virus vaccine R&D and quality research and has a good ability of team management. 

        Dr. Zhou Lingyun holds a bachelor's degree in bioengineering and a doctorate in biochemistry from East China University of Science and Technology. From 2010 to 2011, she conducted post-doctoral research in the College of Biomedical Engineering, University of Arkansas. So far, she has undertaken quality researches of many municipal and national projects ("the 12th Five-Year Plan", "the 13th Five-Year Plan" major new drug development.